F. Hoffmann-La Roche Ltd – Strategy, SWOT and Corporate Finance Report

F. Hoffmann-La Roche Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

F. Hoffmann-La Roche Ltd (Roche) is a biotechnology company, which develops drugs and diagnostics to treat major diseases. It provides pharmaceuticals in cancer, neuroscience, infection, immunology, ophthalmology, cardiovascular and metabolism, hematology, neurology and respiratory disease areas. The company also provides in vitro diagnostics and tissue-based cancer diagnostics, besides diabetes management solutions. Roche conducts research to identify novel methods to prevent, diagnose and treat diseases. The company offers its products and services to hospitals, commercial diagnostic laboratories, healthcare professionals, researchers and pharmacists. Together with its subsidiaries and partners, the company has operations in various countries all over the world. Roche is headquartered in Basel, Switzerland.

Scope

Detailed information on F. Hoffmann-La Roche Ltd required for business and competitor intelligence needs

A study of the major internal and external factors affecting F. Hoffmann-La Roche Ltd in the form of a SWOT analysis

An in-depth view of the business model of F. Hoffmann-La Roche Ltd including a breakdown and examination of key business segments

News about F. Hoffmann-La Roche Ltd, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of F. Hoffmann-La Roche Ltd and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess F. Hoffmann-La Roche Ltd as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on F. Hoffmann-La Roche Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Takeda Pharmaceutical Co Ltd

Sanofi

Pfizer Inc

Novartis AG

Merck & Co Inc

Johnson & Johnson

GlaxoSmithKline Plc

Eli Lilly and Co

Bristol-Myers Squibb Co

Bayer AG

AstraZeneca Plc

Astellas Pharma Inc

Amgen Inc

AbbVie Inc

Abbott Laboratories

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

F. Hoffmann-La Roche Ltd - Key Facts

F. Hoffmann-La Roche Ltd - Key Employees

F. Hoffmann-La Roche Ltd - Key Employee Biographies

F. Hoffmann-La Roche Ltd - Major Products and Services

F. Hoffmann-La Roche Ltd - History

F. Hoffmann-La Roche Ltd - Company Statement

F. Hoffmann-La Roche Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 Company Analysis

Company Overview

F. Hoffmann-La Roche Ltd - Business Description

Business Segment: Diagnostics

Overview

Performance

Key Stats

Business Segment: Pharmaceuticals

Overview

Performance

Key Stats

Geographical Segment: Africa, Australia and Oceania

Performance

Geographical Segment: Asia

Performance

Geographical Segment: Europe

Performance

Geographical Segment: Latin America

Performance

Geographical Segment: North America

Performance

R&D Overview

F. Hoffmann-La Roche Ltd - Corporate Strategy

F. Hoffmann-La Roche Ltd - SWOT Analysis

SWOT Analysis - Overview

F. Hoffmann-La Roche Ltd - Strengths

F. Hoffmann-La Roche Ltd - Weaknesses

F. Hoffmann-La Roche Ltd - Opportunities

F. Hoffmann-La Roche Ltd - Threats

F. Hoffmann-La Roche Ltd - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences Financial Deals and Alliances

F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

F. Hoffmann-La Roche Ltd, Recent Deals Summary

Section 5 Company’s Recent Developments

Feb 06, 2019: Chugai Pharmaceutical has announced that Roche has joined the World Federation of Hemophilia (WFH) Humanitarian Aid Program, an initiative leading the effort to change the lack of acce...Read more

Feb 05, 2019: Roche submits supplemental biologics license application to US FDA for Kadcyla for adjuvant treatment of people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment

Jan 31, 2019: Roche reports very strong results in 2018

Jan 24, 2019: Genentech announces Alexander Hardy as Chief Executive Officer

Jan 17, 2019: FDA accepts Roche’s supplemental biologics license application for Tecentriq plus chemotherapy (Abraxane and carboplatin) for the initial treatment of metastatic non-squamous non-small cell lung cancer

Jan 15, 2019: Roche launches uPath enterprise software with improved speed, performance and usability for digital pathology

Dec 17, 2018: PRIME designation granted by European Medicines Agency for Roche's risdiplam for treatment of spinal muscular atrophy (SMA)

Dec 12, 2018: Roche, Merck partner to develop pan-cancer companion diagnostic test

Dec 10, 2018: New member proposed for election to Roche Board of Directors

Dec 05, 2018: FDA grants priority review to Roche’s Tecentriq in combination with chemotherapy for the initial treatment of extensive-stage small cell lung cancer

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

F. Hoffmann-La Roche Ltd, Key Facts

F. Hoffmann-La Roche Ltd, Key Employees

F. Hoffmann-La Roche Ltd, Key Employee Biographies

F. Hoffmann-La Roche Ltd, Major Products and Services

F. Hoffmann-La Roche Ltd, History

F. Hoffmann-La Roche Ltd, Subsidiaries

F. Hoffmann-La Roche Ltd, Key Competitors

F. Hoffmann-La Roche Ltd, Ratios based on current share price

F. Hoffmann-La Roche Ltd, Annual Ratios

F. Hoffmann-La Roche Ltd, Annual Ratios (Cont…1)

F. Hoffmann-La Roche Ltd, Annual Ratios (Cont…2)

F. Hoffmann-La Roche Ltd, Interim Ratios

F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

F. Hoffmann-La Roche Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

F. Hoffmann-La Roche Ltd, Performance Chart (2014 – 2018)

F. Hoffmann-La Roche Ltd, Ratio Charts

F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports